Expertise in
1
conditions

Tiewei Lv

Ministry Of Education Key Laboratory Of Child Development And Disorders, National Clinical Key Cardiovascular Specialty, Chongqing Municipal Health Commission Key Laboratory Of Children's Vital Organ Development And Diseases, 
Chongqing, CN 
Expertise in
1
conditions
Ministry Of Education Key Laboratory Of Child Development And Disorders, National Clinical Key Cardiovascular Specialty, Chongqing Municipal Health Commission Key Laboratory Of Children's Vital Organ Development And Diseases, 
Chongqing, CN 

Overview

Tiewei Lv practices practicing medicine in Chongqing, China.

Lv is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Restrictive Cardiomyopathy (RCM), Ventricular Septal Defects, Cardiomyopathy, and Enlarged Liver.

They are actively involved in clinical research, co-authoring 30 peer reviewed articles.

Locations

Ministry Of Education Key Laboratory Of Child Development And Disorders, National Clinical Key Cardiovascular Specialty, Chongqing Municipal Health Commission Key Laboratory Of Children's Vital Organ Development And Diseases, Chongqing, 401122, China
Other Locations
Chongqing Key Laboratory Of Child Infection And Immunity, Chongqing Key Laboratory Of Pediatric, Ministry Of Education Key Laboratory Of Child Development And Disorders, No.136 Zhongshan Erd Road, Yuzhong District, Zhongshan, 400014, China
136 Zhongshan Er Road, Chongqing, Yuzhong, 400014, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

30 Total Publications

A Novel tsRNA, 5'tiRNA-GluCTC, Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Fibrosis in Restrictive Cardiomyopathy.
A Novel tsRNA, 5'tiRNA-GluCTC, Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Fibrosis in Restrictive Cardiomyopathy.
Journal: Clinical science (London, England : 1979)
Published: December 28, 2025

Frequently Asked Questions about Tiewei Lv

Is Tiewei Lv a top-rated expert for Restrictive Cardiomyopathy (RCM)?

MediFind is an objective health platform that identifies experts based on real-world data. Tiewei Lv is classified as an Distinguished expert for Restrictive Cardiomyopathy (RCM), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tiewei Lv participate in research or clinical trials?

Yes. Tiewei Lv has published 30 articles and abstracts on conditions like Restrictive Cardiomyopathy (RCM). You can view a list of Tiewei Lv's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lv's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile